Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

308
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
308
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

257
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
257
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

287
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
287
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

249
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
249
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

274
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
274
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

748
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
748

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Performance patterns and records in the world aquatics masters championships: Where do the most frequently represented nations among the top-ten masters swimmers come from?

PloS one·2026
Same author

Feasibility and Preliminary Outcomes of a Machine-Based Pilates Program on Quality of Life and Low Back Pain in Aged Adults: A Mixed-Methods Approach.

Medicina (Kaunas, Lithuania)·2026
Same author

The Role of Body Image Discrepancy in Exercise and Eating Motivation: A Self-Determination Theory Perspective.

Healthcare (Basel, Switzerland)·2026
Same author

The Moderating Role of Sports Attitudes in the Association Between Attitudes Toward Violence and Sexual Harassment.

Behavioral sciences (Basel, Switzerland)·2026
Same author

Neurofeedback in Football: A Systematic Review of Cognitive, Technical, Physical and Psychological Outcomes.

NeuroSci·2026
Same author

Effects of Dual-Task Versus Multicomponent Exercise Programs on Fear of Falling and Fall Risk in Institutionalized Older Adults: A Randomized Controlled Trial.

Healthcare (Basel, Switzerland)·2026

Related Experiment Video

Updated: Feb 22, 2026

Author Spotlight: Innovations in iTUG Test for Enhanced Risk Assessment and Cognitive Insights
05:26

Author Spotlight: Innovations in iTUG Test for Enhanced Risk Assessment and Cognitive Insights

Published on: October 25, 2024

1.8K

Interactions Between BMI and Age on Fall Risk in Older Adults.

Filipe Rodrigues1,2, Diogo Monteiro1,2, António Miguel Monteiro3,4

  • 1ESECS-Polytechnic of Leiria, 2411-901 Leiria, Portugal.

Epidemiologia (Basel, Switzerland)
|February 20, 2026
PubMed
Summary
This summary is machine-generated.

Obesity increases fall risk in older adults aged 60-79. However, in those over 80, normal weight may not protect against falls due to potential muscle loss (sarcopenia).

Keywords:
agingfall riskfunctional fitnessobesity paradoxsarcopenia

More Related Videos

Walk with Me Hybrid Virtual/In-Person Walking for Older Adults with Neurodegenerative Disease
07:21

Walk with Me Hybrid Virtual/In-Person Walking for Older Adults with Neurodegenerative Disease

Published on: June 16, 2023

1.6K
A Training Program Using an Agility Ladder for Community-Dwelling Older Adults
14:13

A Training Program Using an Agility Ladder for Community-Dwelling Older Adults

Published on: March 7, 2020

11.5K

Related Experiment Videos

Last Updated: Feb 22, 2026

Author Spotlight: Innovations in iTUG Test for Enhanced Risk Assessment and Cognitive Insights
05:26

Author Spotlight: Innovations in iTUG Test for Enhanced Risk Assessment and Cognitive Insights

Published on: October 25, 2024

1.8K
Walk with Me Hybrid Virtual/In-Person Walking for Older Adults with Neurodegenerative Disease
07:21

Walk with Me Hybrid Virtual/In-Person Walking for Older Adults with Neurodegenerative Disease

Published on: June 16, 2023

1.6K
A Training Program Using an Agility Ladder for Community-Dwelling Older Adults
14:13

A Training Program Using an Agility Ladder for Community-Dwelling Older Adults

Published on: March 7, 2020

11.5K

Area of Science:

  • Gerontology
  • Public Health
  • Kinesiology

Background:

  • Aging is linked to decreased functional fitness and increased fall likelihood.
  • Obesity is a known factor in reduced mobility, but its interaction with aging and fall risk requires further study.
  • Understanding these relationships is crucial for fall prevention in older adults.

Purpose of the Study:

  • To investigate the combined influence of age, sex, and Body Mass Index (BMI) on fall risk in community-dwelling older adults.
  • To identify specific age groups and BMI categories where fall risk is significantly elevated.
  • To explore potential mechanisms, such as sarcopenia, contributing to fall risk in advanced age.

Main Methods:

  • A cross-sectional study of 815 older adults (mean age 70.45 years).
  • Participants were stratified by age (60s, 70s, 80s) and BMI (normal, overweight, obese).
  • Fall risk was measured using the Timed Up and Go test, analyzed with Three-Way ANOVA.

Main Results:

  • No significant interaction was found between age, sex, and BMI, nor a main effect of sex on fall risk.
  • A significant interaction between age and BMI was observed (p=0.007).
  • Obesity significantly increased fall risk in individuals in their 60s and 70s compared to normal weight, but not in those in their 80s.

Conclusions:

  • Obesity is a significant fall risk factor for adults aged 60-79.
  • A 'weight paradox' exists in octogenarians, where normal weight offers no protection, possibly due to sarcopenia.
  • Age-tailored fall risk assessments and weight management, emphasizing muscle mass preservation in the elderly, are recommended.